Namida Lab develops rapid diagnostic solutions utilizing biomarker detection techniques to enhance the efficiency of healthcare testing. Their technology significantly decreases the time and cost of disease diagnosis, leading to improved patient outcomes and better resource allocation in healthcare facilities.
Funding
$29.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods of breast cancer screening often involve clinic visits, specialized equipment, and can be costly, limiting accessibility and potentially delaying early detection. This can lead to later-stage diagnoses and reduced treatment options for affected individuals.
Solution
Namida Lab is developing accessible cancer screening tools, including Auria and Melody, that leverage proteomic tear testing for early breast cancer detection. Auria is an at-home screening test that empowers women to proactively monitor their breast health. Melody is a clinical diagnostic tool designed for use by healthcare providers in walk-in clinics, eliminating the need for specialized equipment or personnel. Both products analyze tear samples to identify cancer biomarkers, providing a less invasive and more accessible alternative to traditional screening methods. The company's platform aims to transform cancer screening by making it more accurate, affordable, and effective.
Target Audience
The primary target audience includes women seeking proactive and accessible breast cancer screening options, healthcare providers looking for efficient diagnostic tools, and employers aiming to provide accessible breast health benefits to their employees.
Features
- Auria: At-home biological breast cancer screening test utilizing tear-based biomarker analysis.
- Melody: Clinical tear-based breast cancer diagnostic for providers, suitable for walk-in clinics.
- Proteomic tear testing platform for identifying cancer biomarkers with high precision and accuracy.
- Accessible and affordable screening options compared to traditional methods.
- Designed for early detection to improve health outcomes.